Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Account Payables: 2019-2024

Historic Change in Account Payables for Praxis Precision Medicines (PRAX) over the last 6 years, with Dec 2024 value amounting to $6.7 million.

  • Praxis Precision Medicines' Change in Account Payables fell 71.64% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 100.22%. This contributed to the annual value of $6.7 million for FY2024, which is 175.81% up from last year.
  • Praxis Precision Medicines' Change in Account Payables amounted to $6.7 million in FY2024, which was up 175.81% from -$8.9 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Change in Account Payables registered a high of $7.3 million during FY2021, and its lowest value of -$8.9 million during FY2023.
  • In the last 3 years, Praxis Precision Medicines' Change in Account Payables had a median value of $3.9 million in 2022 and averaged $583,333.
  • Per our database at Business Quant, Praxis Precision Medicines' Change in Account Payables soared by 656.98% in 2021 and then plummeted by 327.52% in 2023.
  • Over the past 5 years, Praxis Precision Medicines' Change in Account Payables (Yearly) stood at $960,000 in 2020, then soared by 656.98% to $7.3 million in 2021, then plummeted by 46.44% to $3.9 million in 2022, then slumped by 327.52% to -$8.9 million in 2023, then skyrocketed by 175.81% to $6.7 million in 2024.